Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Charles

Showing results (431-440 of 519) with videos related to

Pageof 52
Sort By:
American Journal of Clinical Oncology|May 5, 2018
Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker PlacementWilliam M Mendenhall, Gail Sarto, Curtis M Bryant, et al.
Breast Cancer Research and Treatment|October 27, 2017
Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patientsCarlo Palmieri, Rob C Stein, Xinxue Liu, et al.
Clinical Chemistry|May 17, 2015
Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancerDavid S Guttery, Karen Page, Allison Hills, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
[11C]choline positron emission tomography in estrogen receptor-positive breast cancerKaiyumars B Contractor, Laura M Kenny, Justin Stebbing, et al.
Breast Cancer Research and Treatment|June 15, 2017
IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patientsCarlo Palmieri, Rob C Stein, Xinxue Liu, et al.
Plos One|November 9, 2013
Influence of plasma processing on recovery and analysis of circulating nucleic acidsKaren Page, David S Guttery, Nathalie Zahra, et al.
The Lancet. Oncology|February 3, 2007
Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled studyRobert E Coleman, Linda M Banks, Samia I Girgis, et al.
Gene|March 15, 1990
Isolation and characterization of the rat glutamine synthetase-encoding geneL van de Zande, W T Labruyère, A C Arnberg, et al.
Metallomics : Integrated Biometal Science|April 20, 2021
Zinc stable isotopes in urine as diagnostic for cancer of secretory organsKathrin Schilling, Rebekah E T Moore, Kaj V Sullivan, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate CancerCurtis Bryant, Tamara L Smith, Randal H Henderson, et al.
Pageof 52

Showing results (431-440 of 519) with videos related to

Sort By:
Pageof 52
American Journal of Clinical Oncology|May 5, 2018
Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker PlacementWilliam M Mendenhall, Gail Sarto, Curtis M Bryant, et al.
Breast Cancer Research and Treatment|October 27, 2017
Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patientsCarlo Palmieri, Rob C Stein, Xinxue Liu, et al.
Clinical Chemistry|May 17, 2015
Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancerDavid S Guttery, Karen Page, Allison Hills, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
[11C]choline positron emission tomography in estrogen receptor-positive breast cancerKaiyumars B Contractor, Laura M Kenny, Justin Stebbing, et al.
Breast Cancer Research and Treatment|June 15, 2017
IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patientsCarlo Palmieri, Rob C Stein, Xinxue Liu, et al.
Plos One|November 9, 2013
Influence of plasma processing on recovery and analysis of circulating nucleic acidsKaren Page, David S Guttery, Nathalie Zahra, et al.
The Lancet. Oncology|February 3, 2007
Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled studyRobert E Coleman, Linda M Banks, Samia I Girgis, et al.
Gene|March 15, 1990
Isolation and characterization of the rat glutamine synthetase-encoding geneL van de Zande, W T Labruyère, A C Arnberg, et al.
Metallomics : Integrated Biometal Science|April 20, 2021
Zinc stable isotopes in urine as diagnostic for cancer of secretory organsKathrin Schilling, Rebekah E T Moore, Kaj V Sullivan, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate CancerCurtis Bryant, Tamara L Smith, Randal H Henderson, et al.
Pageof 52